TickerFacts.

Silence Therapeutics plc (SLN): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

141.69M
Year ended 2025-12-31
+13.6%
3-year compound annual growth
2022-12-31: 96.58M2023-12-31: 111.28M2024-12-31: 138.75M2025-12-31: 141.69M141.69M
2022-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31141.69M+2.1%2026-03-05, From 2025-01-01
2024-12-31138.75M+24.7%2026-03-05, From 2024-01-01
2023-12-31111.28M+15.2%2025-02-27, From 2023-01-01
2022-12-3196.58Mn/a2025-02-27, From 2022-01-01